Davis Polk advised Roche Holdings, Inc. in connection with its Rule 144A/Regulation S offering of $650 million aggregate principal amount of 1.750% notes due 2022 and $850 million aggregate principal amount of 2.375% notes due 2027, guaranteed by Roche Holding Limited.

Headquartered in Basel, Switzerland, the Roche Group is a leader in research-focused health care with combined strengths in pharmaceuticals and diagnostics, and operates in more than 100 countries and employs more than 91,700 people worldwide.

The Davis Polk corporate team included partner John Banes, counsel Amy T. Alter and associate Josef Schmidt. Partner John D. Paton, counsel Alon Gurfinkel and associate Omer Harel provided tax advice. Members of the Davis Polk team are based in the London and Paris offices.